[go: up one dir, main page]

GB201507109D0 - Methods for the treatment of cardiovascular disorders - Google Patents

Methods for the treatment of cardiovascular disorders

Info

Publication number
GB201507109D0
GB201507109D0 GBGB1507109.5A GB201507109A GB201507109D0 GB 201507109 D0 GB201507109 D0 GB 201507109D0 GB 201507109 A GB201507109 A GB 201507109A GB 201507109 D0 GB201507109 D0 GB 201507109D0
Authority
GB
United Kingdom
Prior art keywords
treatment
methods
cardiovascular disorders
cardiovascular
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1507109.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galapagos NV
Original Assignee
Galapagos Nv And Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos Nv And Abbvie Inc filed Critical Galapagos Nv And Abbvie Inc
Priority to GBGB1507109.5A priority Critical patent/GB201507109D0/en
Publication of GB201507109D0 publication Critical patent/GB201507109D0/en
Priority to RS20230922A priority patent/RS64677B1/en
Priority to EP16712378.5A priority patent/EP3283114B1/en
Priority to ES16712378T priority patent/ES2959612T3/en
Priority to CA2982629A priority patent/CA2982629C/en
Priority to PL16712378.5T priority patent/PL3283114T3/en
Priority to HUE16712378A priority patent/HUE063820T2/en
Priority to US15/566,002 priority patent/US10376520B2/en
Priority to KR1020177032860A priority patent/KR102747428B1/en
Priority to EA201792265A priority patent/EA037911B1/en
Priority to HK18109990.1A priority patent/HK1250624B/en
Priority to CN201680021723.7A priority patent/CN107438609B/en
Priority to MX2017013103A priority patent/MX386902B/en
Priority to BR112017021589-6A priority patent/BR112017021589B1/en
Priority to JP2017553315A priority patent/JP6898249B2/en
Priority to HRP20231192TT priority patent/HRP20231192T1/en
Priority to SM20230328T priority patent/SMT202300328T1/en
Priority to SG11201708198SA priority patent/SG11201708198SA/en
Priority to PCT/EP2016/057103 priority patent/WO2016165952A1/en
Priority to NZ735883A priority patent/NZ735883B2/en
Priority to AU2016248727A priority patent/AU2016248727B2/en
Ceased legal-status Critical Current

Links

GBGB1507109.5A 2015-04-13 2015-04-27 Methods for the treatment of cardiovascular disorders Ceased GB201507109D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB1507109.5A GB201507109D0 (en) 2015-04-27 2015-04-27 Methods for the treatment of cardiovascular disorders
AU2016248727A AU2016248727B2 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
HK18109990.1A HK1250624B (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
MX2017013103A MX386902B (en) 2015-04-13 2016-03-31 METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS.
ES16712378T ES2959612T3 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
CA2982629A CA2982629C (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
PL16712378.5T PL3283114T3 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
HUE16712378A HUE063820T2 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular diseases
US15/566,002 US10376520B2 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
KR1020177032860A KR102747428B1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
EA201792265A EA037911B1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
RS20230922A RS64677B1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
CN201680021723.7A CN107438609B (en) 2015-04-13 2016-03-31 Methods for treating cardiovascular disorders
EP16712378.5A EP3283114B1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
BR112017021589-6A BR112017021589B1 (en) 2015-04-13 2016-03-31 USE OF COMPOUNDS THAT INHIBIT JAK1 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS AND/OR DRUGS FOR THE TREATMENT OF ATHEROSCLEROSIS AND/OR DYSLIPIDEMIA
JP2017553315A JP6898249B2 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
HRP20231192TT HRP20231192T1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
SM20230328T SMT202300328T1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
SG11201708198SA SG11201708198SA (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
PCT/EP2016/057103 WO2016165952A1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
NZ735883A NZ735883B2 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1507109.5A GB201507109D0 (en) 2015-04-27 2015-04-27 Methods for the treatment of cardiovascular disorders

Publications (1)

Publication Number Publication Date
GB201507109D0 true GB201507109D0 (en) 2015-06-10

Family

ID=53488691

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1507109.5A Ceased GB201507109D0 (en) 2015-04-13 2015-04-27 Methods for the treatment of cardiovascular disorders

Country Status (1)

Country Link
GB (1) GB201507109D0 (en)

Similar Documents

Publication Publication Date Title
IL285151B1 (en) Methods of treating fgf21-associated disorders
IL279308A (en) Methods for treating hepcidin-mediated disorders
IL279627A (en) Method for the treatment of depression
IL259133A (en) Gemcabene combinations for the treatment of cardiovascular disease
IL247515A0 (en) Cenicriviroc for the treatment of fibrosis
IL259861A (en) Methods and compositions for the treatment of seizure-related disorders
HUE044021T2 (en) Composition for the treatment of acne
IL257908A (en) Methods for the treatment of epilepsy
SG11201609993YA (en) Treatment of immune disorders
IL246721B (en) Derivatives of 5-benzylisoquinoline for the treatment of cardiovascular diseases
SG11201708181RA (en) Methods for the treatment of inflammatory disorders
PL3484475T3 (en) 1-methylnicotinamide for the treatment of cardiovascular disease
IL253617A0 (en) Cenicriviroc for the treatment of fibrosis
GB201607388D0 (en) Treatment of impulsivity-related disorders
SG11201609522TA (en) Methods for treating cardiovascular diseases
IL251736B (en) Methods and compositions for the treatment of radiation-related disorders
IL270819A (en) Methods for the treatment of chronic pouchitis
SG11201708198SA (en) Methods for the treatment of cardiovascular disorders
GB201512139D0 (en) Methods of treatment
GB201521542D0 (en) Methods for the treatment of cardiovascular disorders
GB201513991D0 (en) Methods for the treatment of cardiovascular disorders
GB201513344D0 (en) Methods for the treatment of Cardiovascular disorders
GB201507109D0 (en) Methods for the treatment of cardiovascular disorders
GB201506228D0 (en) Methods For The Treatment Of Cardivascular Disorders
GB201521543D0 (en) Methods for the treatment of inflammatory disorders

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: GALAPAGOS NV

Free format text: FORMER OWNERS: GALAPAGOS NV;ABBVIE INC.

AT Applications terminated before publication under section 16(1)